Acute nicotine-Induced tachyphylaxis is differentially manifest in the limbic system

Neuropsychopharmacology

Volumn 36, Issue 12, 2011, Pages 2498-2512

  Zuo, Yantao ^a,d   Lu, Hanbing ^a   Vaupel, D Bruce ^a   Zhang, Yi ^b   Chefer, Svetlana I ^a   Rea, William R ^a   Moore, Anna V ^c   Yang, Yihong ^a   Stein, Elliot A ^a  

^a NATIONAL INSTITUTE ON DRUG ABUSE   (United States)

^b NATIONAL INSTITUTE OF MENTAL HEALTH   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

^d DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

nicotine; phMRI; relative cerebral blood volume; tolerance

Indexed keywords

NICOTINE;

AMYGDALOID NUCLEUS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD BRAIN BARRIER; BRAIN BLOOD VESSEL; BRAIN BLOOD VOLUME; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DOSE RESPONSE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; HIPPOCAMPUS; LIMBIC SYSTEM; MALE; NEOCORTEX; NERVE CELL; NEUROBIOLOGY; NEUROIMAGING; NONHUMAN; NUCLEUS ACCUMBENS; PHARMACODYNAMICS; PRIORITY JOURNAL; RAT; SUBSTANTIA NIGRA; TACHYPHYLAXIS; THALAMUS; TOBACCO; TOBACCO DEPENDENCE;

ANIMALS; DOSE-RESPONSE RELATIONSHIP, DRUG; LIMBIC SYSTEM; MALE; NICOTINE; RATS; RATS, SPRAGUE-DAWLEY; TACHYPHYLAXIS;

EID: 80054764388     PISSN: 0893133X     EISSN: 1740634X     Source Type: Journal    
DOI: 10.1038/npp.2011.139     Document Type: Article

References (91)

1. Aceto MD, Awaya H, Martin B, May EL (1983). Antinociceptive action of nicotine and its methiodide derivatives in mice and rats. Br J Pharmacol 79: 869-876. (Pubitemid 13025888)
2. Albuquerque EX, Alkondon M, Pereira EFR, Castro NG, Schrattenholz A, Barbosa CT et al (1997). Properties of neuronal nicotinic acetylcholine receptors: Pharmacological characterization and modulation of synaptic function. J Pharmacol Exp Ther 280: 1117-1136. (Pubitemid 27166705)
3. Albuquerque EX, Pereira EFR, Alkondon M, Rogers SW (2009). Mammalian nicotinic acetylcholine receptors: From structure to function. Physiol Rev 89: 73-120.
4. Alkondon M, Albuquerque EX (2004). The nicotinic acetylcholine receptor subtypes and their function in the hippocampus and cerebral cortex. Prog Brain Res 145: 109-120. (Pubitemid 37442938)
5. Alkondon M, Pereira EFR, Almeida LEF, Randall WR, Albuquerque EX (2000a). Nicotine at concentrations found in cigarette smokers activates and desensitizes nicotinic acetylcholine receptors in CA1 interneurons of rat hippocampus. Neuropharmacology 39: 2726-2739.
6. Alkondon M, Pereira EFR, Eisenberg HM, Albuquerque EX (2000b). Nicotinic receptor activation in human cerebral cortical interneurons: A mechanism for inhibition and disinhibition of neuronal networks. J Neurosci 20: 66-75. (Pubitemid 30220492)
7. Alkondon M, Rocha ES, Maelicke A, Albuquerque EX (1996). Diversity of nicotinic acetylcholine receptors in rat brain. V. a-Bungarotoxin-sensitive nicotinic receptors in olfactory bulb neurons and presynaptic modulation of glutamate release. J Pharmacol Exp Ther 278: 1460-1471.
8. Armitage AK, Hall GH, Sellers CM (1969). Effects of nicotine on electrocortical activity and acetylcholine release from cat cerebral cortex. Br J Pharmacol 35: 152-160.
9. Ashton H, Marsh VR, Millman JE, Rawlins MD, Telford R, Thompson JW (1980). Biphasic dose-related responses of the CNV (contingent negative variation) to I.V. Nicotine in man. Br J Clin Pharmacol 10: 579-589. (Pubitemid 11243330)
10. Ashton H, Millman JE, Telford R, Thompson JW (1974). The effects of caffeine, nitrazepam and cigarette smoking on the contingent negative variation in man. Electroenceph Clin Neurophysiol 37: 59-71.
11. Azam L, Winzer-Serhan W, Leslie FM (2003). Co-expression of a7 and b2 nicotinic acetylcholine receptor subunit mRNA within rat brain cholinergic neurons. Neuroscience 119: 965-977. (Pubitemid 36776447)
12. Barlow RB, Dobson NA (1955). Nicotine monomethiodide. J Pharm Pharmacol 7: 27-34.
13. Brody AL, Mandelkern MA, London ED, Olmstead RE, Farahi J, Scheibal D et al (2006). Cigarette smoking saturates brain a4b2 nicotinic acetylcholine receptors. Arch Gen Psychiatry 63: 907-915. (Pubitemid 44192334)
14. Chin C-L, Pauly JR, Surber BW, Skoubis PD, Mcgaraughty S, Hradil VP et al (2008). Pharmacological MRI in awake rats predicts selective binding of a4b2 nicotinic receptors. Synapse 62: 159-168. (Pubitemid 351186396)
15. Choi JK, Mandeville JB, Chen YI, Kim YR, Jenkins BG (2006). High resolution spatial mapping of nicotine action using pharmacologic magnetic resonance imaging. Synapse 60: 152-157. (Pubitemid 43878124)
16. Clarke PB, Schwartz RD, Paul SM, Pert CB, Pert A (1985). Nicotinic binding in rat brain: Autoradiographic comparison of [3H]acetylcholine, [3H]nicotine, and [125I]-alpha-bungarotoxin. J Neurosci 5: 1307-1315. (Pubitemid 15098442)
17. Corrigall WA, Coen KM (1989). Nicotine maintains robust selfadministration in rats on a limited-access schedule. Psychopharmacology 99: 473-478. (Pubitemid 19273101)
18. Corrigall WA, Coen KM (1991). Selective dopamine antagonists reduce nicotine self-administration. Psychopharmacology 104: 171-176.
19. Cox RW (1996). AFNI: Software for analysis and visualization of functional magnetic resonance neuroimages. Comput Biomed Res 29: 162-173. (Pubitemid 26266657)
20. Dani JA, Bertrand D (2007). Nicotinic acetylcholine receptors and nicotinic cholinergic mechanisms of the central nervous system. Ann Rev Pharmacol Toxicol 47: 699-729.
21. Dani JA, Radcliffe KA, Pidoplichko VI (2000). Variations in desensitization of nicotinic acetylcholine receptors from hippocampus and midbrain dopamine areas. Eur J Pharmacol 393: 31-38. (Pubitemid 30193398)
22. Di Chiara G (2000). Role of dopamine in the behavioral actions of nicotine related to addiction. Eur J Pharmacol 393: 295-314. (Pubitemid 30193428)
23. Dome P, Lazary J, Kalapos MP, Rihmer Z (2010). Smoking, nicotine and neuropsychiatric disorders. Neurosci Biobehav Rev 34: 295-342.
24. Domino EF, Minoshima S, Guthrie S, Ohl L, Ni L, Koeppe RA et al (2000). Nicotine effects on regional cerebral blood flow in awake, resting tobacco smokers. Synapse 38: 313-321.
25. Domino EF, Ni L, Xu Y, Koeppe RA, Guthrie S, Zubieta JK (2004). Regional cerebral blood flow and plasma nicotine after smoking tobacco cigarette. Prog Neuro-Psychopharmacol Biol Psychiatry 28: 319-327. (Pubitemid 38130139)
26. Gotti C, Zoli M, Clementi F (2006). Brain nicotinic acetylcholine receptors: Native subtypes and their relevance. Trends Pharmacol Sci 27: 482-491. (Pubitemid 44251225)
27. Gozzi A, Schwarz A, Reese T, Bertani S, Crestan V, Bifone A (2006). Region-specific effects of nicotine on brain activity: A pharmacological MRI study in the drug-na+ve rat. Neuropsychopharmacology 31: 1690-1703. (Pubitemid 44106700)
28. Guha D, Pradhan SN (1976). Effects of nicotine on EEG and evoked potentials and their interactions with autonomic drugs. Neuropharmacology 15: 225-232.
29. Henningfield JE, Miyasato K, Jasinski DR (1985). Abuse liability and pharmacodynamic characteristics of intravenous and inhaled nicotine. J Pharmacol Exp Ther 234: 1-12. (Pubitemid 15034883)
30. Ji D, Dani JA (2000). Inhibition and disinhibition of pyramidal neurons by activation of nicotinic receptors on hippocampal interneurons. J Neurophysiol 83: 2682-2690. (Pubitemid 30321461)
31. Jones S, Yakel JL (1997). Functional nicotinic ACh receptors on interneurons in the rat hippocampus. J Physiol (Lond) 504: 603-610. (Pubitemid 27493859)
32. Laviolette SR, Alexson TO, van der Krooy D (2002). Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area. J Neurosci 22: 8653-8660. (Pubitemid 35387605)
33. Le Foll BE, Goldberg SE (2005). Nicotine induces conditioned place preferences over a large range of doses in rats. Psychopharmacology 178: 481-492.
34. Le Foll B, Wertheim C, Goldberg SR (2007). High reinforcing efficacy of nicotine in non-human primates. PLoS One 2: E230.
35. Leslie RA, James MF (2000). Pharmacological magnetic resonance imaging: A new application for functional MRI. TiPS 21: 314-318. (Pubitemid 30642922)
36. Levin ED, Bettegowda C, Weaver T, Christopher NC (1998). Nicotine-dizocilpine interactions and working and reference memory performance of rats in the radial-arm maze. Pharmacol Biochem Behav 61: 335-340. (Pubitemid 28498217)
37. Levin ED, Chen E (2004). Nicotinic involvement in memory function in zebrafish. Neurotoxicol Teratol 26: 731-735. (Pubitemid 39296757)
38. Levin ED, McClernon FJ, Rezvani AH (2006). Nicotinic effects on cognitive function: Behavioral characterization, pharmacological specification and anatomic localization. Psychopharmacology 184: 523-539. (Pubitemid 43255869)
39. Li Z, DiFranza JR, Wellman RJ, Kulkarni P, King JA (2008). Imaging brain activation in nicotine-sensitized rats. Brain Res 1199: 91-99.
40. Logothetis NK, Pauls J, Augath M, Trinath T, Oeltermann A (2001). Neurophysiological investigation of the basis of the fMRI signal. Nature 412: 150-157. (Pubitemid 32674704)
41. London ED, Connolly RJ, Szikszay M, Wamsley JK, Dam M (1988). Effects of nicotine on local cerebral glucose utilization in the rat. J Neurosci 8: 3920-3928.
42. Lu H, Patel S, Luo F, Li SJ, Hillard CJ, Ward BD et al (2004). Spatial correlations of laminar BOLD and CBV responses to rat whiskerstimulation with neuronal activity localized by Fos expression. Magn Reson Med 52: 1060-1068. (Pubitemid 39453279)
43. Lu H, Scholl CA, Zuo Y, Demny S, Rea W, Stein EA et al (2010). Registering and analyzing rat fMRI data in the stereotaxic framework by exploiting intrinsic anatomical features. Magn Reson Imaging 28: 146-152.
44. Lu H, Scholl CA, Zuo Y, Stein EA, Yang Y (2007). Quantifying BOLD effect in CBV-weighted fMRI at 9.4T. Magn Reson Med 58: 616-621.
45. Lu H, Yang S, Zuo Y, Demny S, Stein EA, Yang Y (2008). Real-time animal fMRI and its application to neuropharmacological studies. Magn Reson Imaging 26: 1266-1272.
46. Maelicke A, Albuquerque EX (1996). New approach to drug therapy in Alzheimer's disease. Drug Disc Today 1: 53-59. (Pubitemid 126402341)
47. Maisonneuve IM, Mann GL, Deibel CR, Glick SD (1997). Ibogaine and the dopaminergic response to nicotine. Psychopharmacology 129: 249-256. (Pubitemid 27085395)
48. Mandeville JB, Marota JJ, Kosofsky BE, Keltner JR, Weissleder R, Rosen BR et al (1998). Dynamic functional imaging of relative cerebral blood volume during rat forepaw stimulation. Magn Reson Med 39: 615-624. (Pubitemid 28150996)
49. Mansvelder HD, Keath JR, McGehee DS (2002). Synaptic mechanisms underlie nicotine-induced excitability of brain reward areas. Neuron 33: 905-919. (Pubitemid 34246356)
50. Marks MJ, Grady SR, Collins AC (1993). Downregulation of nicotinic receptor function after chronic nicotine infusion. J Pharmacol Exp Ther 266: 1268-1276. (Pubitemid 24175768)
51. Marks MJ, Stitzel JA, Romm E, Weher JM, Collins AC (1986). Nicotinic binding sites in the rat and mouse brain: Comparison of acetylcholine, nicotine and a-bungarotoxin. Mol Pharmacol 30: 427-436. (Pubitemid 17202420)
52. Marota JA, Mandeville JB, Weisskoff RM, Moskowitz MA, Rosen BR, Kosofsky BE (2000). Cocaine activation discriminates dopaminergic projections by temporal response: An fMRI study in rat. NeuroImage 11: 13-23. (Pubitemid 30090152)
53. Martin C, Sibson NR (2008). Pharmacological MRI in animals: A useful tool for 5-HT research? Neuropharmacology 55: 1038-1047.
54. Mathieu-Kia AM, Pages C, Besson M-J (1998). Inducibility of c-Fos protein in visuo-motor system and limbic structures after acute and repeated administration of nicotine n the rat. Synapse 29: 33-354.
55. Matta SG, Balfour DJ, Benowitz NL, Boyd RT, Buccafusco JJ, Caggiula AR et al (2007). Guidelines on nicotine dose selection for in vivo research. Psychopharmacology 190: 269-319. (Pubitemid 46156883)
56. McClung CA, Ulery PG, Perrotti LI, Zachariou V, Berton O, Nestler EJ (2004). DFosB: A molecular switch for long-term adaptation in the brain. Mol Brain Res 132: 146-154. (Pubitemid 39586757)
57. McNamara D, Larson DM, Rapoport SI, Soncrant TT (1990). Preferential metabolic activation of subcortical brain areas by acute administration of nicotine to rats. J Cereb Blood Flow Metab 10: 48-56. (Pubitemid 20035855)
58. Mendelson JH, Goletiani N, Sholar MB, Siegel AJ, Mello NK (2008). Effects of smoking successive low- and high-nicotine cigarettes on hypothalamic- pituitary-adrenal axis hormones and mood in men. Neuropsychopharmacology 33: 749-760. (Pubitemid 351252690)
59. Moore C, Yang Y, Ramage AG (2008). Cardiovascular effects of activation of central a7 and a4b2nAChRs: A role for vasopressin in anaesthetized rats. Br J Pharmacol 153: 1728-1738. (Pubitemid 351545808)
60. Mori T, Zhao X, Zou Y, Aistrup GL, Nishikawa K, Marszalec W et al (2001). Modulation of neuronal nicotinic acetylcholine receptors by halothane in rat cortical neurons. Mol Pharmacol 59: 732-743. (Pubitemid 32274001)
61. Newhouse PA, Potter A, Levin ED (1997). Nicotinic system involvement in Alzheimer's and Parkinson's diseases. Implications for therapeutics. Drugs Aging 11: 206-228. (Pubitemid 27421319)
62. Ochoa EL, Chattopadhyay A, McNamee MG (1989). Desensitization of the nicotinic acetylcholine receptor: Molecular mechanisms and effect of modulators. Cell Mol Neurobiol 9: 141-178. (Pubitemid 19178149)
63. Ochoa EL, Li L, McNamee MG (1990). Desensitization of central cholinergic mechanisms and neuroadaptation to nicotine. Mol Neurobiol 4: 251-287.
64. Paxinos G, Watson C (2005). The Rat Brain in Stereotactic Coordinates 5th edn. Academic Press: San Diego, CA.
65. Perkins KA (2002). Chronic tolerance to nicotine in humans and its relationship to tobacco dependence. Nicotine Tob Res 4: 405-422. (Pubitemid 35469975)
66. Perkins KA, Grobe JE, Epstein LH, Caggiula AC, Stiller RL, Jacob RG (1993). Chronic and acute tolerance to subjective effects of nicotine. Pharmacol Biochem Behav 45: 375-381.
67. Perkins KA, Grobe JE, Fonte C, Goettler J, Caggiula AR, Reynolds WA et al (1994). Chronic and acute tolerance to subjective, behavioral and cardiovascular effects of nicotine in humans. J Pharmacol Exp Ther 270: 628-638. (Pubitemid 24271375)
68. Perry E, Martin-Ruiz C, Lee M, Griffiths M, Johnson M, Piggott M et al (2000). Nicotinic receptor subtypes in human brain ageing, Alzheimer and Lewy body diseases. Eur J Pharmacol 393: 215-222. (Pubitemid 30193419)
69. Pich, EM, Pagliusi SR, Tessari M, Talabot-Ayer D, van Huijsduijnen RH et al (1997). Common neural substrates for the addictive properties of nicotine and cocaine. Science 275: 83-86. (Pubitemid 27020313)
70. Pomerleau OF, Collins AC, Shiffman S, Pomerleau CS (1993). Why some people smoke and other do not: New perspectives. J Counsel Clin Psychol 61: 723-731. (Pubitemid 23304584)
71. Pontieri FE, Tanda G, Orzi F, Di Chiara G (1996). Effects of nicotine on the nucleus accumbens and similarity to those of addictive drugs. Nature 382: 255-258.
72. Quick MW, Lester RAJ (2002). Desensitization of neuronal nicotinic receptors. J Neurobiol 53: 457-478. (Pubitemid 35375579)
73. Ren T, Sagar SM (1992). Induction of c-fos immunostaining in the rat brain after the systemic administration of nicotine. Brain Res Bull 29: 589-597.
74. Rose JE (2007). Multiple brain pathways and receptors underlying tobacco addiction. Biochem Pharmacol 74: 1263-1270. (Pubitemid 47417938)
75. Rowell PP, Li M (1997). Dose-response relationship for nicotineinduced up-regulation of rat brain nicotinic receptors. J Neurochem 68: 1982-1989. (Pubitemid 27176134)
76. Samaha A-N, Yau W-Y W, Yang P, Robinson TE (2005). Rapid delivery of nicotine promotes behavioral sensitization and alters its neurobiological impact. Biol Psychiatry 57: 351-360. (Pubitemid 40215764)
77. Sato A, Sato Y, Uchida S (2002). Regulation of cerebral cortical blood flow by the basal forebrain cholinergic fibers and aging. Auton Neurosci Basic Clin 96: 13-19. (Pubitemid 34158550)
78. Sato A, Sato Y, Uchida S (2004). Activation of the intracerebral cholinergic nerve fibers originating in the basal forebrain increases regional cerebral blood flow in the rat's cortex and hippocampus. Neurosci Lett 361: 90-93. (Pubitemid 38609224)
79. Schochet TL, Kelley AE, Landry CF (2005). Differential expression of arc mRNA and other plasticity-related genes induced by nicotine in adolescent rat forebrain. J Neurosci 135: 285-297. (Pubitemid 41219756)
80. Sheth S, Nemoto M, Guiou M, Walker M, Pouratian N, Toga AW (2003). Evaluation of coupling between optical intrinsic signals and neuronal activity in rat somatosensory cortex. NeuroImage 19: 884-894. (Pubitemid 36918231)
81. Sloan HL, Austin VC, Blamire AM, Schnupp JWH, Lowe AS, Allers KA et al (2010). Regional differences in neurovascular coupling in rat brain as determined by fMRI and electrophysiology. NeuroImage 53: 399-411.
82. Smith AJ, Blumenfeld H, Behar KL, Rothman DL, Shulman RG, Hyder F (2002). Cerebral energetic and spiking frequency: The neurophysiological basis of fMRI. Proc Natl Acad Sci USA 99: 10765-10770.
83. Sorge RE, Clarke PBS (2009). Rats self-administer intravenous nicotine delivered in a novel smoking-relevant procedure: Effects of dopamine antagonists. J Pharmacol Exp Ther 330: 633-640.
84. Stein EA, Pankiewicz J, Harsch HH, Cho J-K, Fuller S A, Hoffman et al (1998). Nicotine-induced limbic cortical activation in the human brain: A functional MRI study. Am J Psychiatry 155: 1009-1015. (Pubitemid 28357723)
85. Suarez SV, Amadon A, Giacomini E, Wiklund A, Changeux JP, Le Bihan D et al (2009). Brain activation by short-term nicotine exposure in anesthetized wild-type and beta2-nicotinic receptors knockout mice: A BOLD fMRI study. Psychopharmacology 202: 599-610.
86. Thomsen MS, Hansen HH, Timmerman DB, Mikkelsen JD (2010). Cognitive improvement by activation of a7 nicotinic acetylcholine receptors: From animal models to human pathophysiology. Curr Pharm Des 16: 323-343.
87. Vallejo YF, Buisson B, Bertrand D, Green WN (2005). Chronic nicotine exposure upregulates nicotinic receptors by a novel mechanism. J Neurosci 25: 5563-5572. (Pubitemid 40800648)
88. Warburton DM, Mancuso G (1998). Evaluation of the information processing and mood effects of a transdermal nicotine patch. Psychopharmacology 135: 305-310. (Pubitemid 28055467)
89. Wonnacott S (1986). Alpha-bungarotoxin binds to lowaffinity nicotine binding sites in rat brain. J Neurochem 47: 1706-1712. (Pubitemid 17191481)
90. Yamashita M, Mori T, Nagata K, Yeh JZ, Narahashi T (2005). Isoflurane modulation of neuronal nicotinic acetylcholine receptors expressed in human embryonic kidney cells. Anesthesiology 102: 76-84. (Pubitemid 40082843)
91. Zubieta J-K, Heitzeg MM, Xu Y, Koeppe RA, Ni L, Guthrie S et al (2005). Regional cerebral blood flow responses to smoking in tobacco smokers after overnight abstinence. Am J Psychiatry 162: 567-577. (Pubitemid 40343925)